Member Upgrade Theronomic Flora Reshape Akkermansia Buy 3 Packs Get Free SGD9 Voucher Pack

Product Overview

Theronomic Flora Reshape Akkermansia employs a complete Tribiotic architecture — integrating a postbiotic, two probiotics, and two prebiotics into a single clinically formulated supplement — to address the increasingly recognised role of Akkermansia muciniphila in gut barrier integrity, metabolic health, and systemic inflammation modulation. Akkermansia muciniphila is a mucin-degrading anaerobic bacterium residing at the gut mucosal layer; clinical research consistently associates higher Akkermansia abundance with improved insulin sensitivity, reduced adipose tissue inflammation, enhanced gut barrier function, and more favourable metabolic markers in human subjects. As a postbiotic, the pasteurised Akkermansia muciniphila MucT™ delivers bioactive components of the bacterium without requiring live organism viability, ensuring stability across storage and gastrointestinal transit conditions and providing regulatory compliance across multiple markets including Australia (TGA ARTG 491665).

The two probiotic strains — Lactobacillus plantarum IMC510 (award-winning strain from clinical metabolic studies) and Bifidobacterium animalis ssp. lactis BLC1 — have been specifically selected for their synergistic effect on gut microbiome rebalancing, with the probiotic strains clinically shown to increase endogenous Akkermansia abundance by 238% and Faecalibacterium prausnitzii populations by over 100% following 8–12 weeks of supplementation. The prebiotic substrates Livaux® (gold kiwifruit polyphenols) and Solnul® (upcycled potato resistant starch) provide selective fermentable substrates that preferentially feed beneficial commensal species, amplifying the probiotic effect and sustaining microbiome diversification. The Member Upgrade bundle (Buy 3 Packs, Get Free SGD9 Voucher) is designed for Singapore EMIS members committed to a structured, minimum 90-day gut rebalancing protocol consistent with clinical study durations.

Product Specifications

Key Applications

• Metabolic health and weight management support: Clinical evidence from a 90-day randomised trial demonstrates significant reductions in body weight (−3.39 kg) and waist circumference (−4.29 cm) without dietary or exercise modification, supporting use in metabolic syndrome, central obesity, and insulin resistance management under clinician supervision.
• Gut barrier integrity restoration: Akkermansia muciniphila MucT™ strengthens the intestinal mucosal layer by promoting mucin production and tight junction protein expression, reducing intestinal permeability implicated in systemic inflammation, food sensitivities, and metabolic endotoxaemia.
• Microbiome rebalancing post-antibiotic therapy: The combined Tribiotic approach — postbiotic Akkermansia, two probiotic strains, and two prebiotic substrates — supports structured microbiome restoration following antibiotic-induced dysbiosis, with selective substrate support for beneficial commensal repopulation.
• Inflammatory bowel condition adjunct support: Elevated Akkermansia abundance is inversely correlated with intestinal inflammation markers; supplementation may complement standard medical management of IBD-spectrum conditions. Patients should consult a gastroenterologist before commencing supplementation for inflammatory bowel conditions.
• Preventive gut health maintenance: For Singapore adults with low dietary fibre intake, high-stress lifestyles, or documented microbiome diversity deficits (e.g., post-AMILI Gut Microbiome Test), the Tribiotic approach provides a structured, evidence-based gut health restoration protocol.
• Sustained 90-day protocol for Singapore EMIS members: The three-pack member upgrade bundle aligns supplementation duration with clinical study periods, with a free SGD9 voucher providing additional value for members on the EMIS Care Membership programme pursuing comprehensive gut and metabolic health improvement.

Frequently Asked Questions

Q: What is Akkermansia muciniphila and why is it clinically significant?
A: Akkermansia muciniphila is a Gram-negative anaerobic bacterium that colonises the intestinal mucus layer and constitutes approximately 1–3% of the healthy adult gut microbiome. It plays a critical role in maintaining gut barrier integrity by stimulating mucin production, strengthening tight junction proteins between enterocytes, and modulating innate immune signalling. Clinical studies published in peer-reviewed journals including Nature Medicine and Cell Metabolism have associated higher Akkermansia abundance with improved insulin sensitivity, reduced adipose tissue inflammation, lower cardiometabolic risk, and more favourable body composition parameters — making it one of the most extensively studied next-generation probiotic organisms in precision gut health medicine.

Q: Why does Flora Reshape use pasteurised (postbiotic) Akkermansia rather than live organisms?
A: Akkermansia muciniphila is a strict anaerobe that does not survive conventional probiotic manufacturing, encapsulation, or gastrointestinal transit in viable form. Research led by Prof. Patrice Cani (UCLouvain) has demonstrated that pasteurised (heat-inactivated) Akkermansia MucT™ retains the bioactive surface protein Amuc_1100 responsible for its gut barrier and metabolic effects, with equivalence or superiority to live organisms in relevant clinical outcomes. Pasteurisation also enables consistent potency dosing (30 Billion Cells guaranteed), stability at ambient temperature, and TGA regulatory compliance for registered therapeutic goods in Australia (ARTG 491665).

Q: What do the clinical trial results show and is this applicable to Singapore populations?
A: The 90-day randomised controlled trial on Lactobacillus plantarum IMC510 (a key probiotic strain in Flora Reshape) demonstrated statistically significant reductions in body weight (−3.39 kg), waist circumference (−4.29 cm), and BMI in overweight human participants without dietary modification. While the primary clinical evidence was generated in European cohorts, the metabolic mechanisms (gut microbiome modulation, mucosal barrier enhancement, systemic inflammation reduction) are physiologically universal. Given Singapore's high prevalence of metabolic syndrome, type 2 diabetes, and central adiposity, the formulation's mechanism of action is directly clinically relevant to Singapore's adult population health priorities.

Q: Is Theronomic Flora Reshape Akkermansia suitable for use alongside prescription medications in Singapore?
A: Theronomic Flora Reshape Akkermansia is classified as a health supplement and is not a therapeutic product under the HSA Singapore Health Products Act. The product is registered with the TGA Australia (ARTG 491665) as a complementary medicine. No clinically significant drug interactions have been reported for the probiotic strains or prebiotic substrates at recommended doses. Patients taking immunosuppressants, antifungal agents, or those with severe immunocompromise should consult their physician before commencing probiotic supplementation, consistent with international clinical guidelines on probiotic safety in vulnerable populations.

Q: How does the EMIS Member Upgrade bundle differ from purchasing individual packs?
A: The Member Upgrade bundle provides three packs of Theronomic Flora Reshape Akkermansia — the minimum recommended supplementation duration for measurable gut microbiome and metabolic outcomes (90 days) — with an additional SGD9 voucher redeemable against future EMIS purchases, providing incremental value for enrolled EMIS Care Membership holders. The bundle price reflects a cost-per-day reduction compared to individual pack procurement, supporting adherence to clinically recommended continuous supplementation protocols without the need for repeat individual orders.